The FTC and HHS asked for stakeholder feedback on generic drug shortages, which could have implications for the 340B program.
FTC, HHS Seek Comments on Role of GPOs, Wholesalers on Generic Drug Shortages
The Federal Trade Commission (FTC) and the Department of Health and Human Services (HHS) are requesting comments on how group [...]
Please Login or Become a Paid Subscriber to View this Content
If you are already a paid subscriber, please follow the steps below.